Halpern, E.
Massachusetts General Hospital,
United States
2024 Rank: 102577
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 882 out of 116246 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 102577 | 110121 |
| Total Cites | 27024 | 29964 |
| H-index | 85 | 92 |
| Hm-index | 30 | 31 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 26 | 26 |
| Number of Single+First Authored Papers | 5 | 5 |
| Total Cites to Single+First Authored Papers | 146 | 154 |
| Number of Single+First+Last Authored Papers | 31 | 31 |
| Total Cites to Single+First+Last Authored Papers | 887 | 992 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 23386 | 25105 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.19 |
| Self-Citation Percentage |
9.81%
|
|
Halpern, E.
Massachusetts General Hospital,
United States
2023 Rank: 103596
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 920 out of 109758 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 103596 | 109857 |
| Total Cites | 25792 | 28671 |
| H-index | 82 | 89 |
| Hm-index | 28 | 30 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 24 | 24 |
| Number of Single+First Authored Papers | 5 | 5 |
| Total Cites to Single+First Authored Papers | 140 | 148 |
| Number of Single+First+Last Authored Papers | 30 | 30 |
| Total Cites to Single+First+Last Authored Papers | 800 | 902 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 22240 | 23923 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.20 |
| Self-Citation Percentage |
10.04%
|
|
Halpern, E.
Massachusetts General Hospital,
United States
2022 Rank: 102905
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 924 out of 105572 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 102905 | 109130 |
| Total Cites | 24274 | 27061 |
| H-index | 79 | 85 |
| Hm-index | 28 | 30 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 19 | 19 |
| Number of Single+First Authored Papers | 5 | 5 |
| Total Cites to Single+First Authored Papers | 132 | 140 |
| Number of Single+First+Last Authored Papers | 30 | 30 |
| Total Cites to Single+First+Last Authored Papers | 742 | 843 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 20898 | 22530 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.20 |
| Self-Citation Percentage |
10.30%
|
|
Halpern, E.
Massachusetts General Hospital,
United States
2021 Rank: 100578
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Nuclear Medicine & Medical Imaging
SubField 2:
Oncology & Carcinogenesis
Rank in SubField 1: 911 out of 101860 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 100578 | 106346 |
| Total Cites | 23430 | 26111 |
| H-index | 77 | 84 |
| Hm-index | 27 | 29 |
| Number of Single Authored Papers | 2 | 2 |
| Total Cites to Single Authored Papers | 19 | 19 |
| Number of Single+First Authored Papers | 5 | 5 |
| Total Cites to Single+First Authored Papers | 129 | 137 |
| Number of Single+First+Last Authored Papers | 31 | 31 |
| Total Cites to Single+First+Last Authored Papers | 718 | 812 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 20178 | 21760 |
| Ratio of Total Citations to Distinct Citing Papers | 1.16 | 1.20 |
| Self-Citation Percentage |
10.27%
|
|